KEGG   DRUG: Lovotibeglogene autotemcel
Entry
D12765                      Drug                                   
Name
Lovotibeglogene autotemcel (USAN/INN);
Lyfgenia (TN)
Product
LYFGENIA (bluebird bio)
Remark
Product: D12765<US>
Efficacy
Hematologic disease treatment
  Disease
Sickle cell disease [DS:H00229]
  Type
Cellular therapy product
Comment
Treatment of sickle cell disease
Target
CD34 [HSA:947] [KO:K06474]
  Pathway
hsa04514  Cell adhesion molecules
hsa04640  Hematopoietic cell lineage
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD34
     D12765  Lovotibeglogene autotemcel (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D12765
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12765
Other DBs
PubChem: 497621178
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system